These findings reinforce the oncogenic role of FAM3B. However, its downregulation in EBV-positive samples aligns with clinical and scientific evidence suggesting that EBV infection in gastric cancer is associated with a favorable prognosis. The gene discussed is FAM3B; the disease is Epstein-Barr virus infection.